Product

Mycobacterium Vaccae

1 clinical trial

1 indication

Indication

Latent Tuberculosis Infection

Clinical trial

Phase IV Clinical Trial of the Safety, Efficacy, and Immunogenicity of Mycobacterium Vaccae for Injection (Mica) in People Over 15 Years of Age With Latent Mycobacterium Tuberculosis Infection

Status: Recruiting, Estimated PCD: 2026-09-30